Novel feeding device may decrease risk of FTT in newborns with congenital heart defects

NewsGuard 100/100 Score

A novel feeding device developed at the University of Pennsylvania School of Nursing may decrease the risk of failure to thrive (FTT), which currently affects half of all newborns with congenital heart defects even after their surgical lesions are corrected.

Professor and nurse practitioner Barbara Medoff-Cooper, PhD, CRNP, of Penn Nursing invented a device that analyzes an infant's ability to organize feeding by sucking, swallowing, and breathing effectively. This device, developed in collaboration with Penn bioengineers, allows healthcare professionals to assess infants at risk for dysfunctional feeding and poor weight gain as often seen in both premature infants and infants with complex congenital heart disease. The data also can be correlated with growth or developmental problems that may occur during the first year of life.

"Feeding actually speaks loudly to us about the brain," says Dr. Medoff-Cooper. "If a child is feeding well, it gives us one fewer major issue to worry about. Conversely, even a full-term infant who is not feeding well is at high risk for developmental problems."

Dr. Medoff-Cooper conducted the first comprehensive evaluation of feeding difficulties in infants with complex congenital heart defects. Her work has demonstrated that feeding behaviors can predict developmental outcomes in high-risk infants because of the complicated interplay of movements and physiologic responses needed in the feeding process. The premise of her work is that feeding effectiveness corresponds to how well infants will achieve other developmental milestones.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
FDA announces recall of heart pumps linked to deaths and injuries